Alembic Share Price
Start SIP in Alembic
Start SIPAlembic Performance
Day Range
- Low 137
- High 140
52 Week Range
- Low 76
- High 169
- Open Price139
- Previous Close138
- Volume451428
Alembic Investment Rating
-
Master Rating:
-
Alembic (Nse) has an operating revenue of Rs. 171.43 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 65% is great, ROE of 12% is good. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 21% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 59 which is a POOR score indicating inconsistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 47 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 49 | 48 | 38 | 31 | 36 | 36 |
| Operating Expenses Qtr Cr | 30 | 24 | 25 | 22 | 26 | 23 |
| Operating Profit Qtr Cr | 19 | 23 | 13 | 10 | 10 | 13 |
| Depreciation Qtr Cr | 2 | 1 | 3 | 2 | 2 | 2 |
| Interest Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Qtr Cr | 2 | 3 | 1 | 4 | 1 | -2 |
| Net Profit Qtr Cr | 17 | 21 | 11 | 51 | 9 | 4 |
Alembic Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 5
- Bearish Moving Average
- ___
- 11
- 20 Day
- ₹141.37
- 50 Day
- ₹142.34
- 100 Day
- ₹134.03
- 200 Day
- ₹119.41
- 20 Day
- ₹140.60
- 50 Day
- ₹147.62
- 100 Day
- ₹133.43
- 200 Day
- ₹113.73
Alembic Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 138.95 |
| Second Resistance | 141.02 |
| Third Resistance | 142.25 |
| RSI | 40.55 |
| MFI | 40.21 |
| MACD Single Line | -3.02 |
| MACD | -3.23 |
| Support | |
|---|---|
| First Support | 135.65 |
| Second Support | 134.42 |
| Third Supoort | 132.35 |
Alembic Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 484,056 | 24,004,337 | 49.59 |
| Week | 634,968 | 25,309,817 | 39.86 |
| 1 Month | 842,473 | 36,386,415 | 43.19 |
| 6 Month | 2,210,681 | 78,965,517 | 35.72 |
Alembic Result Highlights
Alembic Synopsis
NSE-Medical-Diversified
Alembic Ltd. is involved in the business activities of Real estate activities with own or leased property. Company’s Total Operating Revenue is Rs. 152.25 Cr. and Equity Capital is Rs. 51.36 Cr. for the Year ended 31/03/2024. Alembic Ltd. is a Public Limited Listed company incorporated on 30/07/1907 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L26100GJ1907PLC000033 and registration number is 000033.| Market Cap | 3,515 |
| Sales | 166 |
| Shares in Float | 7.45 |
| No of funds | 51 |
| Yield | 1.75 |
| Book Value | 4.35 |
| U/D Vol ratio | 1.3 |
| LTDebt / Equity | 1 |
| Alpha | 0.07 |
| Beta | 1.39 |
Alembic Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 |
|---|---|---|---|
| Promoters | 70.88% | 70.88% | 70.88% |
| Foreign Portfolio Investors | 1.42% | 1.07% | 0.89% |
| Financial Institutions/ Banks | 0.04% | 0.04% | 0.04% |
| Individual Investors | 21.7% | 22.23% | 22.54% |
| Others | 5.96% | 5.78% | 5.65% |
Alembic Management
| Name | Designation |
|---|---|
| Mr. Chirayu Amin | Chairman |
| Mrs. Malika Amin | Managing Director & CEO |
| Mr. Udit Amin | Director |
| Mr. Abhijit Joshi | Director |
| Mrs. Rati Desai | Independent Director |
| Mr. Sameer Khera | Independent Director |
| Mr. Mayank Amin | Independent Director |
| Dr. Girish Hirode | Independent Director |
Alembic Forecast
Price Estimates
Alembic Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-12 | Quarterly Results | |
| 2024-05-13 | Audited Results & Final Dividend | |
| 2024-02-14 | Quarterly Results | |
| 2023-11-08 | Quarterly Results | |
| 2023-08-10 | Quarterly Results |
| Date | Purpose | Remarks |
|---|---|---|
| 2024-08-05 | FINAL | Rs.2.40 per share(120%)Final Dividend |
| 2023-08-03 | FINAL | Rs.2.20 per share(110%)Final Dividend |
| 2022-09-13 | FINAL | Rs.1.80 per share(90%)Dividend |
Alembic FAQs
What is Share Price of Alembic ?
Alembic share price is ₹136 As on 15 October, 2024 | 07:42
What is the Market Cap of Alembic ?
The Market Cap of Alembic is ₹3514.6 Cr As on 15 October, 2024 | 07:42
What is the P/E ratio of Alembic ?
The P/E ratio of Alembic is 12.5 As on 15 October, 2024 | 07:42
What is the PB ratio of Alembic ?
The PB ratio of Alembic is 1.6 As on 15 October, 2024 | 07:42
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.